Trial intelligence / Profile preview

Irbesartan for Prevention of Atrial Arrhythmias in Pacemaker Patients (IPACE)

NCT00225667Phase 3Unknown

Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of irbesartan in Atrial fibrillation (AFib). Status: unknown.

02

Drugs

irbesartan
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00225667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00225667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call